| Literature DB >> 35711963 |
Debora Policastro1, Eugenia Giorno1, Francesca Scarpelli1, Nicolas Godbert1, Loredana Ricciardi1,2, Alessandra Crispini1, Angela Candreva1, Fabio Marchetti3, Sonila Xhafa3, Renata De Rose4, Antonello Nucera5, Riccardo C Barberi2,5, Marco Castriota2,5, Loredana De Bartolo6, Iolinda Aiello1,2.
Abstract
The improvement of the antioxidant and antimicrobial activities of chitosan (CS) films can be realized by incorporating transition metal complexes as active components. In this context, bioactive films were prepared by embedding a newly synthesized acylpyrazolonate Zn(II) complex, [Zn(QPhtBu)2(MeOH)2], into the eco-friendly biopolymer CS matrix. Homogeneous, amorphous, flexible, and transparent CS@Znn films were obtained through the solvent casting method in dilute acidic solution, using different weight ratios of the Zn(II) complex to CS and characterized by powder X-ray diffraction (PXRD), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), Fourier transform infrared (FT-IR), Raman, and scanning electron microscopy (SEM) techniques. The X-ray single-crystal analysis of [Zn(QPhtBu)2(MeOH)2] and the evaluation of its intermolecular interactions with a protonated glucosamine fragment through hydrogen bond propensity (HBP) calculations are reported. The effects of the different contents of the [Zn(QPhtBu)2(MeOH)2] complex on the CS biological proprieties have been evaluated, proving that the new CS@Znn films show an improved antioxidant activity, tested according to the DPPH method, with respect to pure CS, related to the concentration of the incorporated Zn(II) complex. Finally, the CS@Znn films were tried out as antimicrobial agents, showing an increase in antimicrobial activity against Gram-positive bacteria (Staphylococcus aureus) with respect to pure CS, when detected by the agar disk-diffusion method.Entities:
Keywords: Zn(II) complex; antimicrobial activity; antioxidant activity; chitosan; films
Year: 2022 PMID: 35711963 PMCID: PMC9194505 DOI: 10.3389/fchem.2022.884059
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.545
FIGURE 1Molecular structure of the [Zn(QPhtBu)2(MeOH)2] complex (A) with atomic numbering scheme and (B) crystal packing view showing the predominant O–H–N interactions [O (3)–N (1) 2.798 (2) Å, O (3)-H (3a)...N (1) 164°, i = x, -y+1/2, z+1/2].
FIGURE 2Representative Raman spectra collected on (A) the [Zn(QPhtBu)2(MeOH)2] complex in the solid crystalline phase in the ranges between 250 cm−1 and 1,650 cm−1 and between 2800 cm−1 and 3200 cm−1 (in the inset) and (B) on CS in the ranges between 275 cm−1 and 1750 cm−1 and between 2650 cm−1 and 3500 cm−1.
FIGURE 4PXRD patterns of the complex [Zn(QPhtBu)2(MeOH)2] and the ionic CS films and CI% values calculated for the CS films.
FIGURE 3XRD profile of the control CS film with its deconvolution curves (crystalline peaks: red lines; amorphous region: blue curve; cumulative fit curve: yellow line).
FIGURE 5SEM images of the prepared films, up: images of the surface; down: corresponding cross section (scale bars 10 μm).
FIGURE 6Photograph of the CS@Zn10% film on the molecular structure of the [Zn(QPhtBu)2(MeOH)2] complex.
FIGURE 7Proposed model scheme of the plausible intermolecular hydrogen bonds between [Zn(QPhtBu)2(MeOH)2] and CS in the formation of the CS@Znn films.
FIGURE 8Absorption spectra of DPPH ethanolic solution (control) and after incubation for 3 (A) and 24 h (B), with chitosan films incorporating different amounts of the [Zn(QPhtBu)2(MeOH)2] complex. (C) Picture of DPPH working solutions after 24 h of incubation with the samples CS@Znn. The discoloration of the solution is proportional to the antioxidant ability of the sample and increases with the increasing [Zn(QPhtBu)2(MeOH)2] complex loading rate.
DPPH scavenging ability of [Zn(QPhtBu)2(MeOH)2], CS, CS@AAn (AA = ascorbic acid; n = 1.25 and 10%), and CS@Znn films.
| Sample | Antioxidant Activity (%) 3 h | Antioxidant Activity (%) 24 h |
|---|---|---|
| [Zn(QPhtBu)2(MeOH)2] | 2.82 ± 0.12 | 3.14 ± 0.14 |
| CS | 7.94 ± 0.22 | 10.85 ± 0.11 |
| CS@AA1.25% | 8.09 ± 0.31 | 12.82 ± 0.22 |
| CS@Zn1.25% | 9.68 ± 0.37 | 17.34 ± 0.18 |
| CS@Zn2.5% | 14.45 ± 0.15 | 29.11 ± 0.31 |
| CS@Zn5% | 19.07 ± 0.45 | 38.15 ± 0.26 |
| CS@Zn7.5% | 20.8 ± 0.14 | 47.96 ± 0.52 |
| CS@Zn10% | 21.53 ± 0.34 | 48.26 ± 0.47 |
| CS@AA10% | 11.27 ± 0.15 | 28.20 ± 0.12 |
FIGURE 9Inhibitory effect of CS and CS@Znn films on the growth of Staphylococcus aureus (A) and Escherichia coli (B).
The diameter (mm) of the inhibition zone of CS and CS@Znn films including the diameter of the disk (6 mm). The data are reported as the average of four determinations ±SD.
| Film Type | Chitosan/Zn Complex % (p/p) | Diameter of Inhibitory Zone | Diameter of Inhibitory Zone E. coli (mm) |
|---|---|---|---|
| CS | 0% | 7.0 ± 0,8 | 7.0 ± 0.6 |
| CS@Zn1.25% | 1.25% | 9.0 ± 0.2 | 7.2 ± 0.4 |
| CS@Zn2.5% | 2.5% | 9.9 ± 0.5 | 7.5 ± 0.2 |
| CS@Zn5% | 5% | 10.9 ± 0,4 | 7.5 ± 0.1 |
| CS@Zn7.5% | 7.5% | 11.4 ± 0.1 | 7.8 ± 0.2 |
| CS@Zn10% | 10% | 11.9 ± 0.5 | 7.9 ± 0.2 |